Interferon beta in multiple sclerosis: is IL-12 suppression the key?
Karp
C L
CL
Depts of Medicine and Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD 21205, USA. ckarp@jhmi.edu
Biron
C A
CA
Irani
D N
DN
D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016899:Interferon-beta / Q000494:pharmacology*; D018664:Interleukin-12 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis*; D009103:Multiple Sclerosis / Q000209:etiology / Q000276:immunology* / Q000628:therapy*
D007166:Immunosuppressive Agents; D018664:Interleukin-12; D016899:Interferon-beta